Latest

CSPC PHARMA (01093.HK): SYS6090 monotherapy Phase I/II data in advanced solid tumours out, HCC ORR at 40.0% ] CSPC PHARMA (01093.HK) said SYS6090 Phase I/II data in advanced solid tumours presented at ESMO 2026; ORR 40.0% in HCC, 21.1% in CRC and over 30.0% in NSCLC.
19:30
CSPC PHARMA01093.HKESMO
TIANGONG INT'L (00826.HK): Tiangong Aihe wins BEST fusion device shielding system bid, about 4 tonnes of powder metallurgy high-boron steel, RMB2.376 million ] TIANGONG INT'L (00826.HK) said its unit won a bid to supply about 4 tonnes of powder metallurgy high-boron steel parts for the BEST device at RMB2.376 million.
19:27
TIANGONG INT00826.HKwon the bid
CITIC BANK (00998.HK): redemption and delisting of RMB35 billion domestic preference shares completed, RMB36.428 billion paid ] CITIC BANK (00998.HK) completed the redemption and delisting of its RMB35 billion preference shares, paying RMB36.428 billion in nominal value and dividends.
19:05
CITIC BANK00998.HKBond Redemption
SHANDONG MOLONG(00568.HK): 2026 Nine-Month Report - Profit Attributable to Shareholders stood at loss of CNY 95.18 million, turned into a loss from a profit YoY ] October 27, 2026, SHANDONG MOLONG(00568.HK) released its Nine-Month Report for the period ended December 31, 2026, Total Revenue stood at CNY 1.77 billion, increased by 48.05% YoY.
19:02
SHANDONG MOLONG00568.HKturned into a loss from a profit
GRAPHEX GROUP (06128.HK): placing of 188.26 million shares completed, net proceeds HK$8.9 million, warrant exercise price cut to HK$0.05 ] GRAPHEX GROUP (06128.HK) placed 188.26 million new shares at HK$0.050 each for net proceeds of about HK$8.9 million, and cut warrant exercise price to HK$0.05.
19:01
GRAPHEX GROUP06128.HKPlacing
SUNEVISION (01686.HK): SHKP Group converts convertible notes, public float 15.10%, 10% alternative threshold adopted ] SUNEVISION (01686.HK) issued 1,719,427,500 shares to SHKP Group on note conversion, leaving a 15.10% public float, so it adopts the 10% alternative threshold.
18:55
SUNEVISION01686.HKPublic Float
AV CONCEPT HOLD (00595.HK): So Kevin Chi Heng steps down as COO, Ip Hing Lam appointed chief operating officer ] AV CONCEPT HOLD (00595.HK) said So Kevin Chi Heng ceased as chief operation officer and Ip Hing Lam became chief operating officer from 1 October 2026.
18:53
AV CONCEPT HOLD00595.HKManagement Change
SKB BIO (06990.HK): seventh sac-TMT indication filing accepted, first-line PD-L1-negative non-squamous NSCLC ] SKB BIO (06990.HK) said the NMPA accepted a seventh indication filing for sac-TMT, combined with pembrolizumab in first-line PD-L1-negative non-squamous NSCLC.
18:20
SKB BIO06990.HKNew Drug Application
HENGRUI PHARMA (01276.HK): remimazolam tosilate approved for ICU mechanical ventilation sedation, R&D spend RMB222.5 million ] HENGRUI PHARMA (01276.HK) won NMPA approval for new indication of Remimazolam Tosilate for Injection: sedation during mechanical ventilation in intensive care.
18:16
HENGRUI PHARMA01276.HKDrug Approval
NANYA NEW MATERIAL (688519.SH): plans H-share offering and HKEX listing, details not yet fixed, control unchanged ] NANYA NEW MATERIAL (688519.SH) is planning an H-share offering and HK listing, with details and approvals pending and no change in control expected.
17:58
NANYA NEW MATERIAL688519.SHH-share Listing Plan
MINSHENG EDU (01569.HK): tribunal upholds claimants' RMB2.18 billion exit price, set-aside proceedings ongoing ] MINSHENG EDU (01569.HK) said the HKIAC tribunal upheld the claimants' RMB2,180,735,560.50 exit price and found the option validly exercised in 2021.
17:53
MINSHENG EDU01569.HKLitigation
NAGACORP (03918.HK): appoints Yeap Chee Wan as INED, annual fee US$73,000, joins three committees ] NAGACORP (03918.HK) appointed Yeap Chee Wan as an INED and a member of three board committees from 27 October 2026, with an annual fee of US$73,000.
17:49
NAGACORP03918.HKexecutive director
ANDRE JUICE (02218.HK): RMB 792.79 mln Yongqiang deal closes ] On 27 October 2026, ANDRE JUICE (02218.HK) completed the acquisition of a 62.0611% stake in Ningbo Yongqiang for RMB 792.79 million and has consolidated it.
17:44
ANDRE JUICE02218.HKacquisition
CHUANGLIAN HOLD (02371.HK): Use of subscription proceeds detailed ] On 27 October 2026, CHUANGLIAN HOLD (02371.HK) said remitting HKD 20 million from China by dividend would cost HKD 2.1 million to 2.2 million, or 10.5% to 11%.
17:37
CHUANGLIAN HOLD02371.HK
LIVZON PHARMA (01513.HK): Tiange Dingxuan wins trial approval ] On 27 October 2026, LIVZON PHARMA (01513.HK) said its subsidiary won approval to test Tiange Dingxuan Granules for vestibular migraine, a first in China.
17:32
LIVZON PHARMA01513.HKR&D Progress
SINO HOTELS (01221.HK): Lau Ip Keung named independent director ] On 27 October 2026, SINO HOTELS (01221.HK) appointed Lau Ip Keung as an independent non-executive director for three years, with an annual fee of HKD 150,000.
17:17
SINO HOTELS01221.HK
CHINA RE (01508.HK): Domestic share issue cleared by CSRC ] On 27 October 2026, CHINA RE (01508.HK) said the CSRC approved its registration for a targeted issue of Domestic Shares, with the approval valid for 12 months.
17:14
CHINA RE01508.HKDomestic Shares
LIVZON PHARMA (01513.HK): Wandai Tang Granules win approval ] On 27 October 2026, LIVZON PHARMA (01513.HK) said its subsidiary won a Drug Registration Certificate for Wandai Tang Granules, the first approved in China.
17:09
LIVZON PHARMA01513.HKR&D Progress
HK shares ETFs Daily Report: iShares CSI 300 A-Share Index ETF Rises 3.59% to Lead as STAR 50 and Biotech Pull Back — October 27, 2026 ] On October 27, 2026, Hong Kong ETFs split between regional markets and technology hardware. iShares CSI 300 A-Share Index ETF (02846.HK) rose 3.59% to lead, with four Korea-related and two semiconductor ETFs in the top ten, while STAR 50 and biotech themes pulled back, led by Bosera SZSE ChiNext Daily (2x) Leveraged Product (07234.HK) down 6.04% and every top-ten decliner down at least 3.13%; only four Southbound (Stock Connect) ETFs gained.
16:51
HK Shares ETFs Daily ReportiShares CSI 300 A-Share Index ETFBosera Szse Chinext Daily (2x) Leveraged Product
Hong Kong Recently Listed Stocks Daily Report: BRAINAURORA-B Leads with 27.13% Gain on Medical Technology as Semiconductors and Medical Devices Both Stay Active - 20261027 ] On October 27, 2026, BRAINAURORA-B rose 27.13% to top the gainers while NEW GONOW RV fell 33.40% to lead the decliners; Z.AI led on liquidity with turnover of HKD 5.108 billion; MABWELL-B and XIZHI TECH-P will see lock-up releases tomorrow.
16:33
Hong Kong Recently Listed Stocks Daily ReportBRAINAURORA-BESWIN COMPUTINGNEW VISION CO
Previous1..910 111213..606     606 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments